Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2005-07-04

Original market date: See footnote 1

1997-04-16

Product name:

HYPAQUE-M 76%

DIN:

02180677 Electronic product monograph is not available

Company:

AMERSHAM HEALTH INC
2300 Meadowvale Blvd.
Mississauga
Ontario
Canada L5N 5P9

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intravenous ,  Intra-Arterial

Number of active ingredient(s):

2

Schedule(s):

Ethical

 

American Hospital Formulary Service (AHFS): See footnote 3

36:68.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

V08AA01 DIATRIZOIC ACID

Active ingredient group (AIG) number:See footnote5

0201807001

List of active ingredient(s)
Active ingredient(s) Strength
DIATRIZOATE MEGLUMINE 66 %
DIATRIZOATE SODIUM 10 %
Version 4.0.2
Date modified: